| Similar Articles |
|---|
 |
The Motley Fool
July 26, 2006
Stephen D. Simpson |
Aspect Gives Investors Nightmares The med tech company continues to grow, but high volatility is likely to follow.   |
The Motley Fool
February 3, 2006
Stephen D. Simpson |
Phase 2 for Intuitive Surgical Now that the initial rush is over, it's time for Intuitive Surgical to build a lasting business. Investors need to be careful with this one. |
The Motley Fool
April 20, 2006
Stephen D. Simpson |
More Predictable Unpredictability at ICU Hidden beneath all of the volatility is a pretty decent med-tech business. Recent volatility was the kind that investors like. The stock spiked up as earnings exceeded analyst estimates and the business did a fair bit better than management had projected at the end of last quarter. |
BusinessWeek
April 17, 2006
Gene G. Marcial |
A Fresh Prospect For Aspect Some investors are starting to see Aspect Medical Systems, tops in brain monitoring, in a new light. |
The Motley Fool
July 27, 2006
Stephen D. Simpson |
Growth Ingrates Dump Intuitive Surgical Despite today's sell-off, Intuitive Surgical remains a red-hot grower in the med-tech space. |
The Motley Fool
February 2, 2006
Stephen D. Simpson |
Cytyc Still Stands On Its Own Despite apparent doubts about some mergers, the med-tech company is still growing strongly. Investors, take note. |
The Motley Fool
May 9, 2006
Stephen D. Simpson |
NeuroMetrix Has a Lot of Nerve Though an excellent opportunity, the med-tech's price has outpaced value for investors. |
The Motley Fool
July 3, 2006
Stephen D. Simpson |
Encore Takes Final Bow Encore Medical, a med-tech company that could never quite get going, sells out to a private investor. Investors, take note. |
The Motley Fool
July 22, 2005
Stephen D. Simpson |
Bio-Tech's Robot-Coaster Ride Intuitive Surgical is a high-growth, high-opportunity stock with a history of earnings-related volatility. |
The Motley Fool
February 27, 2006
Stephen D. Simpson |
A Foxy Idea? Medical device maker Foxhollow is in an attractive niche, but management turnover is a reason for investors to worry. |
The Motley Fool
October 19, 2005
Stephen D. Simpson |
ICU, You Look Healthier An incredible third quarter shows what operating leverage can do for this little medical technology company. Investors, take note. |
The Motley Fool
May 5, 2006
Stephen D. Simpson |
FoxHollow-ed Out Worries about guidance may be giving investors a second crack at this med-tech stock. |
The Motley Fool
August 4, 2006
Stephen D. Simpson |
SilverHawk Flying Just Fine, Thanks With med-tech company FoxHollow Technologies, there is growth and risk in equal measure. Investors, take note. |
The Motley Fool
January 30, 2006
Stephen D. Simpson |
Don't Hold Your Breath for Kensey Nash It's not over for Kensey Nash -- it will soon be seeing revenue from new partners Medtronic and Zimmer. But the stock's price continues to value this company as a growing med-tech idea. |
The Motley Fool
October 31, 2005
Stephen D. Simpson |
Integra Needs to Grow From Within Acquired growth is nice, but organic growth is the key to long-term success. Quite frankly, the only way this stock works from a cash flow valuation standpoint is if the company does in fact deliver very good growth over the next 10 years or so. |
The Motley Fool
July 27, 2005
Stephen D. Simpson |
Back Pain for Shorts? Kyphon continues to defy its skeptics. A developer of minimally invasive technology for the spine, the company saw revenue in the second quarter grow 48% as the U.S. business grew about 41% and overseas sales climbed 99%. Investors, take note. |
The Motley Fool
February 8, 2005
Stephen D. Simpson |
Kyphon Developing a Backbone The small med-tech company posts a rich valuation, but growth is hot, and the market is huge. |
The Motley Fool
March 9, 2005
Stephen D. Simpson |
The Merits of Merit Medical Living in the gaps created by the big boys is risky for small medical device makers, but it can pay off over time. Merit Medical could hold some merit for patient value portfolios. |
The Motley Fool
May 9, 2005
Stephen D. Simpson |
Integra LifeSciences Strikes a Nerve The med-tech company's missed quarter coupled with some slightly disappointing guidance caused investors to lose a bit of faith, sending the shares down more than 15% at one point. |
The Motley Fool
May 25, 2006
Stephen D. Simpson |
Same Old Patterson Even deep drilling can't unearth a discount at this dental and veterinary supply distributor. What's more aggravating is having to pay this multiple for the business. |
The Motley Fool
January 30, 2006
Stephen D. Simpson |
A Bard's Tale The advanced medical technology company's stock already reflects new products' potential. Still, life in the med-tech sector could get more interesting in the coming quarters. Investors, take note. |
The Motley Fool
April 21, 2006
Stephen D. Simpson |
Bard Rolls On Nothing flashy here, but at the right price, this would be an interesting med-tech play. Investors, take note. |
The Motley Fool
May 9, 2006
Stephen D. Simpson |
Riding the Hospira Yo-Yo There's a solid foundation on this roller coaster pharmaceutical and drug delivery company. Maybe Hospira's current valuation doesn't make it a "gem," but that's not really within its control. |
The Motley Fool
July 31, 2006
Stephen D. Simpson |
Kinetic Concepts Approaches a Binary Outcome The resolution of a patent infringement trial means far more than one quarter's results for this med-tech company. Investors, take note. |
